SCHEMBL6649205

SCHEMBL6649205

CC(C)(C/C=C\C(O)(C(F)(F)F)C(F)(F)F)CCCCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7701604 1.00
SCHEMBL7704895 0.82 CYP4F2 (0.31)
SCHEMBL7704897 0.82 CYP4F2 (0.31)
SCHEMBL7523159 0.81 MLYCD (0.30)
SCHEMBL6651139 0.81 MLYCD (0.30)
SCHEMBL6651466 0.80 ACLY (0.32)
SCHEMBL6651471 0.80 ACLY (0.32)
SCHEMBL7591661 0.71 LMNA (0.38)
SCHEMBL7697346 0.68 CYP4F2 (0.32)
SCHEMBL6448246 0.67 SMN1; SMN2 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1094060-B1 New process for the preparation of retiferol derivatives BASILEA PHARMACEUTICA AG (CH) 2004-04-28 EP disclosed
EP-1056716-B1 CYCLOHEXANEDIOLE DERIVATIVES BASILEA PHARMACEUTICA AG (CH) 2002-12-11 EP disclosed
US-6437142-B1 10,10,10-TRIFLUORO-5,5-DIMETHYL-9-TRIETHYLSILANYLOXY-9-TRIFLUO ROMETHYL-DEC-7-ENAL REACTED WITH TRIETHYL PHOSPHONOACETATE OR ETHYL (TRIMETHYLSILYL) ACETATE AND THEN COUPLING WITH 2-MERCAPTO-BENZOTHIAZOLE BASILEA PHARMACEUTICA AG (CH) 2002-08-20 US disclosed
US-6403346-B1 FOR TREATMENT/PREVENTION OF HYPERPROLIFERATIVE SKIN DISEASES (PSORIASIS) AND REVERSING CONDITIONS ASSOCIATED WITH PHOTODAMAGE BASILEA PHARMACEUTICA AG (CH) 2002-06-11 US disclosed
US-20020028975-A1 Process for preparing retiferol derivatives HILPERT HANS (CH) 2002-03-07 US disclosed
US-6310262-B1 COUPLING CYCLOHEXANONE DERIVATIVE WITH BENZOTHIAZOLE DERIVATIVE TO FORM RETIFEROL DERIVATIVE BASILEA PHARMACEUTICA AG (CH) 2001-10-30 US disclosed
EP-1094060-A2 New process for the preparation of retiferol derivatives F. HOFFMANN-LA ROCHE AG (CH) 2001-04-25 EP disclosed
US-6184422-B1 TREATMENT AND PREVENTION OF HYPERPROLIFERATIVE SKIN DISEASES; REVERSING CONDITIONS ASSOCIATED WITH PHOTODAMAGE; ANTITUMOR, -CARCINOGENIC AGENTS; PSORIASIS; DISORDERS OF NEOPLASTIC DISEASES; KERATINIZATION/KERATOSIS; ACNE; SEBORRHEA HOFFMAN-LA ROCHE INC. 2001-02-06 US disclosed